BioSpace News Archive

Summit Therapeutics plc announced that it achieved the first milestone under its license and collaboration agreement with Eurofarma Laboratórios SA.

Panthera, the newly launched independent clinical trial site management organisation, has opened its first site in Preston in the UK with a second site in North Manchester to open in March.

Have you ever stopped yourself from applying for a position with a high profile, life sciences organization because you thought it wasn’t worth it?

Late-stage data released from Regeneron highlights the importance of proactively providing Eylea to patients who have been diagnosed with moderately severe to severe NDPR.

So far, this has only been demonstrated in mice, but the research shows that the underlying processes are conserved in humans.

Renowned drug discovery leader to guide alliance formed to improve scientific exchange in UK drug discovery community

Funding to support GMP adenovirus manufacture for a first-in-human basket clinical trial in melanoma, lung cancer, and triple negative breast cancer

Mako Medical is lowering pharmacy costs with a new mobile app aimed at pricing transparency and access to lower-cost meds. This new model uses cost-plus pricing — not retail rates.

Hutchison China MediTech Limited announced the availability of updated results from the Phase II CALYPSO study of the savolitinib / Imfinzi® combination in a cohort of patients with metastatic papillary renal cell carcinoma, an investigator initiated study led by Professor Thomas Powles, Lead for Solid Tumour Research at Barts Cancer Centre, and sponsored by Queen Mary University of London.

Clover Biopharmaceuticals announced that it has successfully produced its trimeric Spike-protein subunit vaccine candidate for 2019-nCoV via a mammalian cell expression system.